Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans
about
Withdrawing Benzodiazepines in Primary CarePharmacological interventions for benzodiazepine mono-dependence management in outpatient settingsPharmacological interventions for benzodiazepine mono-dependence management in outpatient settingsClinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.Self-administration of bretazenil under progressive-ratio schedules: behavioral economic analysis of the role intrinsic efficacy plays in the reinforcing effects of benzodiazepinesImidazenil prevention of alprazolam-induced acquisition deficit in patas monkeys is devoid of toleranceVarenicline in the treatment of tobacco dependence.Drugability of extracellular targets: discovery of small molecule drugs targeting allosteric, functional, and subunit-selective sites on GPCRs and ion channels.Case report on the administration of an eighty milligram diazepam injection without respiratory depression.Bretazenil, a benzodiazepine receptor partial agonist, as an adjunct in the prophylactic treatment of OP poisoning.The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines.Safety Pharmacology Society: 9th Annual Meeting.Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects.
P2860
Q22305817-83CFCAE8-260B-46DB-AE07-A557536FA498Q24202319-F4766855-FD92-472D-A43C-D2D31236E6BBQ24245399-DB2FA3D0-75DA-4C6D-9925-1D4A5401A9A8Q34300348-63838DBB-AB7C-49AB-8EDA-59CF3B5ACBCCQ34510925-929D50F8-E943-4C21-B88E-D86ECF9A0DABQ35054106-A7B42E66-1DD6-4804-8F35-DE499C2261ECQ36842193-9B751BAC-7644-4308-9F8A-CA12FF4A10D0Q37272529-42E6A661-24DA-467D-BEAF-A0499EAFCA1BQ43089763-DFAD1C3E-38D1-47E9-A095-DE52B23E6D21Q43938385-64732EDA-3B53-490A-85A0-BB2426E76BCEQ46486014-0F315E95-7C50-472F-A5AD-7AA33EDE65D5Q48309631-8E140DD9-DCC3-44CE-93B8-BE011D868F78Q55057714-72D75608-8918-4DD0-AE07-93C87C8BB690
P2860
Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans
description
1994 nî lūn-bûn
@nan
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Pharmacologic effects and abus ...... epam, and alprazolam in humans
@ast
Pharmacologic effects and abus ...... epam, and alprazolam in humans
@en
Pharmacologic effects and abus ...... epam, and alprazolam in humans
@nl
type
label
Pharmacologic effects and abus ...... epam, and alprazolam in humans
@ast
Pharmacologic effects and abus ...... epam, and alprazolam in humans
@en
Pharmacologic effects and abus ...... epam, and alprazolam in humans
@nl
prefLabel
Pharmacologic effects and abus ...... epam, and alprazolam in humans
@ast
Pharmacologic effects and abus ...... epam, and alprazolam in humans
@en
Pharmacologic effects and abus ...... epam, and alprazolam in humans
@nl
P2093
P921
P356
P1476
Pharmacologic effects and abus ...... epam, and alprazolam in humans
@en
P2093
P304
P356
10.1038/CLPT.1994.55
P407
P577
1994-04-01T00:00:00Z